Skip to content

Treasury Stock at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$1.01B+30.8%
GLW
CorningGLW
-$21.43B-202%
Kewaunee Scientific Corporation logo
Kewaunee Scientific CorporationKEQU
$3.65M0.0%
Danaher logo
DanaherDHR
$12.32B+32.4%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$6.93B+20.5%
WAT
Waters CorporationWAT
$10.17B+0.1%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$211.18B+15.4%
Enterprise value$246.29B+14.1%
P/E30.3×+2.5×
P/S4.7×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's treasury stock?
Thermo Fisher Scientific (TMO) reported treasury stock of $25.36B in Q1 2026.
How has Thermo Fisher Scientific's treasury stock changed year-over-year?
Thermo Fisher Scientific's treasury stock increased by 19.2% year-over-year, from $21.27B to $25.36B.
What is the long-term trend for Thermo Fisher Scientific's treasury stock?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's treasury stock has grown at a 26.8% compound annual growth rate (CAGR), from $6.82B to $22.31B.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.